Other
Prednisolone
0
Pipeline Programs↗
3
Active Trials↗
5
Companies Involved↗
Prednisolone is an early-stage landscape with 0 programs across 5 companies. The most active players are Novartis, Merck & Co., AstraZeneca.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
32
clinical trials
Completed19 · 59%
Unknown status8 · 25%
Recruiting2 · 6%
Terminated1 · 3%
Active, not recruiting1 · 3%
Withdrawn1 · 3%
Clinical Trials
Trial Activity
32 trials
Deflazacort Vs. Prednisolone in Acute-stage ABPA
Active, not recruiting·PPost Graduate Institute of Medical Education and Research, Chandigarh·Phase 2/3·NCT04227483·150 enrolled
Prednisolone Trial in Children Younger Than 4 Years
Completed·—·Phase 3·NCT03141970·170 enrolled
Prednisolone Improves IVF Outcomes in Men With Anti-sperm Antibodies
Completed·BBarz IVF Center for Infertility Treatment and Embryo Research·N/A·NCT02935738·241 enrolled
Intravenous Immunoglobulin and Prednisolone for RPL After ART.
Completed·—·Phase 2·NCT04701034·80 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)